大型抑郁症的药物治疗指南对应性及其与通过症状变化运作的联系
Mason T Breitzig1, Fan He1, Lan Kong1
1Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA.
Journal of clinical and translational science
|September 30, 2024
概括
遵循主要抑郁症 (MDD) 治疗指南可以改善患者的功能. 这种改善主要是由于症状严重程度的降低,而不是遵循指南的直接影响.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 药物治疗 药物治疗
背景情况:
- 大型抑郁症 (MDD) 治疗的目的是缓解症状和功能恢复.
- 对于MDD存在药物治疗指南,但它们对功能结果的影响尚未完全理解.
- 开发了一种指导方针一致算法 (GCA-8) 来评估临床实践中的遵守.
研究的目的:
- 调查MDD患者遵守药物治疗指南与功能恢复之间的关联.
- 确定MDD症状严重程度是否调解了指导方针一致性和功能之间的关系.
主要方法:
- 利用来自临床注册表的1403名非精神病性MDD成年人的数据 (2015-2021年).
- 采用多变量线性回归来分析GCA-8分数与世界卫生组织残疾评估表2.0 (WHODAS) 分数之间的关联.
- 通过使用患者健康问卷抑郁症模块 (PHQ-9) 评估MDD症状严重性的中介作用.
主要成果:
- 在一年内观察到WHODAS得分 (功能) 的统计学上显著改善.
- 增加的指导方针一致性 (GCA-8) 与减少的残疾分数有关,通过减少MDD症状严重程度 (PHQ-9) 有显著的调解效应.
- 准则一致性对功能的直接影响,无论症状严重程度如何,都没有统计学意义.
结论:
- 对药物治疗指南的更高遵守与MDD患者的功能改善有关.
- 准则一致性对功能的积极影响似乎通过减少MDD症状严重程度来调解.
- 这表明,通过遵循指南的治疗来优化症状控制是恢复患者功能的关键.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
200
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
200
Depressive Disorders: MDD and Dysthymia
65
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
65
Diagnostic and Statistical Manual of Mental Disorders (DSM)
48
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
48
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
Depression: Overview
224
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
224
Antidepressant Drugs: Overview
375
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
375


